In Group A, 31 (62%) patients had preoperative hypertension, and all had antihypertensive therapy consisting of angiotensin II receptor blockers, angiotensin-converting enzyme inhibitors, beta-blockers, and calcium channel blockers. This evidence concerns the gene ACE and hypertensive disorder.